Key result
Retroperitoneal sarcoma resection en-bloc with the inferior vena cava achieved comparable median overall survival (59 vs 65 months, P=0.519) and disease-free survival (18 vs 18 months, P=0.604) to resection without vascular involvement.
Why the study?
Does retroperitoneal sarcoma resection en-bloc with inferior vena cava achieve comparable survival to resection without vascular involvement in patients with retroperitoneal sarcoma?
Cohort (n=128)
No
Does retroperitoneal sarcoma resection en-bloc with inferior vena cava achieve comparable survival to resection without vascular involvement in patients with retroperitoneal sarcoma?
p-value: p=0.519
En-bloc resection of the IVC during retroperitoneal sarcoma surgery achieves equivalent overall and disease-free survival compared to resection without vascular involvement.
No takes yet. Share an insight, caveat, or question.
En-bloc IVC resection in RPS yields comparable survival to matched controls; supports feasibility but leaves open need for prospective validation.
Blair et al. (2018) conducted a cohort in Retroperitoneal sarcoma (RPS) (n=128). RPS resection en-bloc with inferior vena cava (IVC) vs. RPS resection without IVC resection was evaluated on Overall survival (OS) and disease free survival (DFS) (p=0.519). Retroperitoneal sarcoma resection en-bloc with the inferior vena cava achieved comparable median overall survival (59 vs 65 months, P=0.519) and disease-free survival (18 vs 18 months, P=0.604) to resection without vascular involvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: